Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.4M Sell
164,559
-1,620
-1% -$396K 0.01% 844
2025
Q4
$42.1M Sell
166,179
-20,931
-11% -$5.26M 0.01% 864
2025
Q3
$46.3M Buy
187,110
+12,433
+7% +$2.98M 0.01% 810
2025
Q2
$42M Sell
174,677
-23,277
-12% -$5.42M 0.01% 785
2025
Q1
$44.9M Buy
197,954
+35,984
+22% +$7.91M 0.01% 690
2024
Q4
$33.3M Buy
161,970
+31,497
+24% +$6.91M 0.01% 838
2024
Q3
$31.6M Sell
130,473
-30,086
-19% -$7.04M 0.01% 847
2024
Q2
$35.2M Buy
160,559
+11,649
+8% +$2.53M 0.01% 732
2024
Q1
$33.5M Sell
148,910
-34,540
-19% -$7.79M 0.01% 775
2023
Q4
$40.3M Buy
183,450
+43,121
+31% +$9.12M 0.01% 765
2023
Q3
$30.8M Buy
140,329
+5,405
+4% +$1.22M 0.02% 638
2023
Q2
$30.4M Buy
134,924
+81,517
+153% +$16.3M 0.02% 599
2023
Q1
$10.2M Sell
53,407
-51,467
-49% -$9.95M ﹤0.01% 1148
2022
Q4
$19.4M Sell
104,874
-94
-0.1% -$16.5K 0.01% 910
2022
Q3
$17.5M Buy
104,968
+35,847
+52% +$7.29M 0.02% 652
2022
Q2
$14.3M Sell
69,121
-51,215
-43% -$11.5M 0.01% 865
2022
Q1
$29.1M Sell
120,336
-40,272
-25% -$9.34M 0.02% 574
2021
Q4
$39.1M Buy
160,608
+9,783
+6% +$2.24M 0.01% 676
2021
Q3
$30.8M Buy
150,825
+22,549
+18% +$4.82M 0.01% 712
2021
Q2
$26.5M Buy
128,276
+32,695
+34% +$6.58M 0.01% 763
2021
Q1
$18.2M Buy
95,581
+19,174
+25% +$3.56M 0.01% 832
2020
Q4
$14.5M Buy
76,407
+10,543
+16% +$1.97M 0.01% 973
2020
Q3
$11.6M Buy
65,864
+319
+0.5% +$51K 0.01% 974
2020
Q2
$10.1M Sell
65,545
-7,078
-10% -$1.08M 0.01% 957
2020
Q1
$10.2M Sell
72,623
-136,583
-65% -$20.4M 0.01% 979
2019
Q4
$31.9M Buy
209,206
+94,347
+82% +$13.8M 0.02% 707
2019
Q3
$16.6M Buy
114,859
+67,047
+140% +$10M 0.01% 992
2019
Q2
$7.12M Buy
+47,812
New +$6.39M ﹤0.01% 1564
2019
Q1
Sell
-45,986
Closed -$5.41M 7316
2018
Q4
$4.91M Sell
45,986
-25,426
-36% -$2.84M ﹤0.01% 1617
2018
Q3
$8.17M Buy
71,412
+27,600
+63% +$3.12M 0.01% 1403
2018
Q2
$4.6M Sell
43,812
-3,505
-7% -$353K ﹤0.01% 1791
2018
Q1
$4.42M Buy
47,317
+37,352
+375% +$3.4M ﹤0.01% 1732
2017
Q4
$871K Sell
9,965
-1,677
-14% -$150K ﹤0.01% 3248
2017
Q3
$1.03M Buy
11,642
+11,133
+2,187% +$944K ﹤0.01% 2976
2017
Q2
$41K Sell
509
-29,376
-98% -$2.23M ﹤0.01% 5464
2017
Q1
$2.08M Sell
29,885
-51,482
-63% -$3.56M ﹤0.01% 2063
2016
Q4
$5.48M Buy
81,367
+26,081
+47% +$1.77M 0.01% 1330
2016
Q3
$4.04M Sell
55,286
-59,214
-52% -$4.18M ﹤0.01% 1457
2016
Q2
$7.87M Sell
114,500
-7,653
-6% -$536K 0.01% 980
2016
Q1
$8.67M Sell
122,153
-158,020
-56% -$10.7M 0.01% 835
2015
Q4
$21M Buy
280,173
+277,352
+9,832% +$20M 0.03% 549
2015
Q3
$180K Sell
2,821
-1,235
-30% -$81.6K ﹤0.01% 4207
2015
Q2
$259K Sell
4,056
-14,791
-78% -$998K ﹤0.01% 3964
2015
Q1
$1.32M Buy
18,847
+11,118
+144% +$734K ﹤0.01% 2717
2014
Q4
$493K Sell
7,729
-2,936
-28% -$181K ﹤0.01% 3879
2014
Q3
$566K Sell
10,665
-11,237
-51% -$611K ﹤0.01% 3846
2014
Q2
$1.16M Sell
21,902
-5,205
-19% -$268K ﹤0.01% 3185
2014
Q1
$1.27M Sell
27,107
-9,820
-27% -$460K ﹤0.01% 2976
2013
Q4
$1.77M Buy
36,927
+5,375
+17% +$246K ﹤0.01% 2799
2013
Q3
$1.33M Buy
31,552
+5,830
+23% +$253K ﹤0.01% 3048
2013
Q2
$1.1M Buy
+25,722
New +$1.11M ﹤0.01% 3238

Other funds holding STE

Barclays's STE Position: Q1 2026 in Review

Barclays reduced its Steris (STE) stake by 0.97% in Q1 2026, selling an estimated $396K and leaving 164,559 shares worth $36.4M. The position accounts for 0.01% of the portfolio, ranked #844.

Barclays first reported a position in STE in Q2 2013 and has held it in 51 quarters since. The position peaked at $46.3M in Q3 2025. 844 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Barclays held 164,559 shares of Steris worth $36.4M as of Q1 2026.
  • Barclays sold 1,620 Steris shares in Q1 2026, an estimated $396K.
  • Steris made up 0.01% of Barclays's portfolio in Q1 2026, its #844 holding.
  • Barclays first reported a position in Steris in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Steris position peaked at $46.3M in Q3 2025.
  • 844 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.